Stocklytics Platform
Asset logo for symbol LFMD
LifeMD
LFMD74
$7.03arrow_drop_up1.00%$0.07
High Growth
Asset logo for symbol LFMD
LFMD74

$7.03

arrow_drop_up1.00%

Performance History

Chart placeholder
Key Stats
Open$6.72
Prev. Close$6.77
EPS-0.74
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range6.72
7.14
52 Week Range3.45
12.88
Ratios
EPS-0.74

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$804.62
Perf. (24h)
arrow_drop_down2.01%-$16.57
Market Cap$738.87B
Price$569.71
Perf. (24h)
arrow_drop_up1.79%$10.03
Market Cap$527.83B
Price$160.64
Perf. (24h)
arrow_drop_up0.62%$1.00
Market Cap$382.01B
Price$185.16
Perf. (24h)
arrow_drop_up1.64%$2.99
Market Cap$326.96B

About LifeMD (LFMD)

LifeMD, Inc. (LFMD) is a healthcare technology company that provides telemedicine services and virtual healthcare. The company offers personalized, comprehensive patient care through its digital platform. With a focus on convenience and accessibility, LifeMD enables patients to connect with healthcare providers remotely, eliminating the need for in-person visits. This innovative approach to healthcare delivery has gained significant traction in recent years, as consumers seek more convenient and efficient ways to access medical care. LifeMD's digital platform includes a range of services, such as virtual consultations, medication delivery, and remote monitoring. By leveraging technology, LifeMD is able to provide high-quality care to patients while reducing costs and improving outcomes. The company is at the forefront of the telemedicine revolution, and its innovative solutions have the potential to revolutionize healthcare delivery worldwide.
LifeMD, Inc. has experienced significant growth since its inception. The company's stock price has seen substantial increases, reflecting market confidence in its business model and growth prospects. Investors have been attracted to LifeMD's innovative approach to healthcare, recognizing the potential for disruption in the traditional healthcare industry. The company's market cap has also increased, reflecting its expanding operations and growing market presence. In addition, LifeMD has a favorable PEG ratio, indicating that its stock price is undervalued relative to its earnings growth. This has made the company an attractive investment opportunity for many investors. LifeMD's performance has outpaced its industry peers, demonstrating its ability to stay competitive in a rapidly evolving market. With a 52-week range that spans from a low to high stock price, LifeMD has shown resilience and adaptability in the face of market fluctuations. Finally, the trading volume of LifeMD's stock has been significant, indicating strong investor interest and activity in the company. This level of trading volume further demonstrates the market's confidence in LifeMD's future growth prospects.
Sector
Healthcare
Industry
Health Information Services
CEO
Mr. Justin Schreiber
Headquarters
New York
Employees
199
Exchange
NASDAQ
add LifeMD to watchlist

Keep an eye on LifeMD

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is LifeMD's (LFMD) price per share?
The current price per share for LifeMD (LFMD) is $7.03. The stock has seen a price change of $0.07 recently, indicating a 1.01% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for LifeMD (LFMD)?
For LifeMD (LFMD), the 52-week high is $12.88, which is 83.21% from the current price. The 52-week low is $3.45, the current price is 103.77% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is LifeMD (LFMD) a growth stock?
LifeMD (LFMD) has shown an average price growth of 0.41% over the past three years. It has received a score of 97 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying LifeMD as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is LifeMD (LFMD) stock price performance year to date (YTD)?
As of the latest data, LifeMD (LFMD) has a year-to-date price change of -16.61%. Over the past month, the stock has experienced a price change of 3.53%. Over the last three months, the change has been -35.03%. Over the past six months, the figure is 18.35%.
help
Is LifeMD (LFMD) a profitable company?
LifeMD (LFMD) has a net income of -$20.6M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 82.61% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -13.98% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $152.55M, with a revenue growth rate of 28.15%, providing insight into the company's sales performance and growth. The gross profit is $126.01M. Operating income is noted at -$14.49M. Furthermore, the EBITDA is -$16.6M.
help
What is the market capitalization of LifeMD (LFMD)?
LifeMD (LFMD) has a market capitalization of $290.63M. The average daily trading volume is 541.58K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level